Assessing the cost‐effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia

Adam J Visconti,J. Doyle,A. Weir,Alan M Shiell,M. Hellard
DOI: https://doi.org/10.1111/jgh.12041
2013-04-01
Journal of Gastroenterology and Hepatology
Abstract:To assess the cost‐effectiveness of hepatitis C virus treatment with pegylated interferon alfa‐2a and ribavirin in current and former people who inject drugs (PWID).
What problem does this paper attempt to address?